ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Performance
- Low
- ₹56
- High
- ₹58
- 52 Week Low
- ₹54
- 52 Week High
- ₹83
- Open Price₹58
- Previous Close₹57
- Volume8,400
Investment Returns
- Over 1 Month -5.09%
- Over 3 Month -7.44%
- Over 6 Month -42.72%
- Over 1 Year -42.72%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 9.5
- PEG Ratio
- -
- Market Cap Cr
- 64
- P/B Ratio
- 3.9
- Average True Range
- 1.68
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- -1.35
- RSI
- 46.83
- MFI
- 40.67
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹57.85
+
0.7
(1.22%)
-
- Bearish Moving Average 8
-
- Bullish Moving Average 5
- 20 Day
- ₹57.95
- 50 Day
- ₹60.26
- 100 Day
- ₹63.68
- 200 Day
- -
Resistance and Support
57.25
- R3 60.25
- R2 59.05
- R1 58.45
- S1 56.65
- S2 55.45
- S3 54.85
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹57 As on 27 October, 2025 | 01:15
The Market Cap of Accretion Pharmaceuticals is ₹64.3 Cr As on 27 October, 2025 | 01:15
The P/E ratio of Accretion Pharmaceuticals is 9.5 As on 27 October, 2025 | 01:15
The PB ratio of Accretion Pharmaceuticals is 3.9 As on 27 October, 2025 | 01:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.